Infliximab effective in steroid-dependent juvenile eosinophilic fasciitis.
Tzaribachev
N
N
Holzer
U
U
Schedel
J
J
Maier
V
V
Klein
R
R
Kuemmerle-Deschner
J
J
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy*; D002648:Child; D004802:Eosinophilia / Q000188:drug therapy*; D005208:Fasciitis / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab